Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in UZ Gasthuisberg Leuven Nierziekten.

During the past decade, UZ Gasthuisberg Leuven Nierziekten conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Gasthuisberg Leuven Nierziekten" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Erasme University Hospital" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator, "Belgian Government" with 1 trials as a collaborator and "Fund for Scientific Research, Flanders, Belgium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "UZ Gasthuisberg Leuven Nierziekten" are "Hepatitis B" (4 trials), "Diabetes Mellitus, Type 1" (2 trials), "Diabetes, Type I" (1 trials), "Islet Transplantation" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "UZ Gasthuisberg Leuven Nierziekten" in a lesser frequency.

Most popular intervention types in "UZ Gasthuisberg Leuven Nierziekten" are "Biological" (4 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "HBVAXPRO vaccine" (2 trials), "ATG-Sirolimus-Tacrolimus" (1 trials), "Actrapid HM" (1 trials), "ChAgly CD3" (1 trials) and "FENDRIX" (1 trials). Other intervention names were less common.

The vast majority of trials in "UZ Gasthuisberg Leuven Nierziekten" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UZ Gasthuisberg Leuven Nierziekten". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in UZ Gasthuisberg Leuven Nierziekten, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UZ Gasthuisberg Leuven Nierziekten, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".